Litcius/Paper detail

Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations

Ondřej Uher, Veronika Caisová, Lucie Paďouková, Karolína Kvardová, Kamila Masáková, Radka Lencova, Andrea Frejlachova, Markéta Skaličková, Anna Venhauerova, Adéla Chlastáková, Per Hansen, Jindrǐch Chmelař, Jan Kopecký, Zhengping Zhuang, Karel Pacák, Jan Ženka

2021Cancer Immunology Immunotherapy17 citationsDOIOpen Access PDF

Topics & Concepts

Cancer researchImmunotherapyCD8Pancreatic cancerAdenocarcinomaMelanomaGenetic enhancementImmunologyCancerAntigenBiologyImmune systemMedicineInternal medicineGeneBiochemistryImmunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology Research
Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations | Litcius